Collagen-mimetic peptide-modifiable hydrogels for articular cartilage regeneration

Biomaterials

Volumn 54, Issue , 2015, Pages 213-225

  Parmar, Paresh A ^a,b   Chow, Lesley W ^a   St Pierre, Jean Philippe ^a   Horejs, Christine Maria ^a,c   Peng, Yong Y ^b   Werkmeister, Jerome A ^b   Ramshaw, John A M ^b   Stevens, Molly M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CSIRO   (Australia)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bioactivity; Biodegradation; Biomimetic material; Cartilage tissue engineering; Hydrogel; Mesenchymal stem cell

Indexed keywords

BIOACTIVITY; BIODEGRADATION; BIOLOGICAL MATERIALS; BIOMIMETIC MATERIALS; BIOMIMETICS; CARTILAGE; CELL CULTURE; CELL ENGINEERING; COLLAGEN; CROSSLINKING; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HYALURONIC ACID; PEPTIDES; PROTEINS; STEM CELLS; TISSUE; TISSUE ENGINEERING;

BIODEGRADABLE HYDROGELS; BIOMECHANICAL FUNCTIONS; CARTILAGE TISSUE ENGINEERING; CHONDROGENIC DIFFERENTIATION; COLLAGEN MIMETIC PEPTIDES; HUMAN MESENCHYMAL STEM CELLS (HMSCS); MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELL;

HYDROGELS;

BACTERIAL PROTEIN; CHONDROITIN SULFATE; COLLAGEN; HYALURONIC ACID; MATRILYSIN; STREPTOCOCCAL COLLAGEN LIKE 2 PROTEIN; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; ARGINYL-GLYCYL-ASPARTYL-SERINE; BIOMIMETIC MATERIAL; HYDROGEL; OLIGOPEPTIDE; SCL2 PROTEIN, STREPTOCOCCUS;

ARTICLE; ARTICULAR CARTILAGE; BIODEGRADABILITY; CELL VIABILITY; CHONDROGENESIS; CONTROLLED STUDY; CROSS LINKING; DEGRADATION KINETICS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYMAL STEM CELL; NANOENCAPSULATION; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; TISSUE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CHONDROCYTE; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; MESENCHYMAL STROMA CELL; PHYSIOLOGY; REGENERATION; SYNTHESIS;

BACTERIAL PROTEINS; BIOMIMETIC MATERIALS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; CHONDROITIN SULFATES; COLLAGEN; HUMANS; HYDROGELS; MATRIX METALLOPROTEINASE 7; MESENCHYMAL STROMAL CELLS; OLIGOPEPTIDES; REGENERATION;

EID: 84928015657     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.079     Document Type: Article

References (54)

1. CDC.Prevalence and most common causes of disability among adults-United States MMWR Morb Mortal Wkly Rep 2005, 2009(58):421-426.
2. Hunter D.J. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat Rev Rheumatol 2011, 7:13-22.
3. Huey D.J., Hu J.C., Athanasiou K.A. Unlike bone, cartilage regeneration remains elusive. Sci 2012, 338:917-921.
4. CDC Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation-United States, 2010-2012. MMWR Morb Mortal Wkly Rep 2013, 62:869-892.
5. Place E.S., Evans N.D., Stevens M.M. Complexity in biomaterials for tissue engineering. Nat Mater 2009, 8:457-470.
6. Langer R., Vacanti J.P. Tissue engineering. Sci 1993, 260:920-926.
7. McCullen S.D., Chow A.G.Y., Stevens M.M. Invivo tissue engineering of musculoskeletal tissues. Curr Opin Biotechnol 2011, 22:715-720.
8. McCullen S.D., Autefage H., Callanan A., Gentleman E., Stevens M.M. Anisotropic fibrous scaffolds for articular cartilage regeneration. Tissue Eng Part A 2012, 18:2073-2083.
9. Steele J.A.M., McCullen S.D., Callanan A., Autefage H., Accardi M.A., Dini D., et al. Combinatorial scaffold morphologies for zonal articular cartilage engineering. Acta Biomater 2014, 10:2065-2075.
10. Chow L.W., Armgarth A., St-Pierre J.-P., Bertazzo S., Gentilini C., Aurisicchio C., et al. Peptide-directed spatial organization of biomolecules in dynamic gradient scaffolds. Adv Healthc Mater 2014, 3:1381-1386.
11. Place E.S., Nair R., Chia H.N., Szulgit G., Lim E.-H., Stevens M.M. Latent TGF-β hydrogels for cartilage tissue engineering. Adv Healthc Mater 2012, 1:480-484.
12. Bryant S.J., Bender R.J., Durand K.L., Anseth K.S. Encapsulating chondrocytes in degrading PEG hydrogels with high modulus: engineering gel structural changes to facilitate cartilaginous tissue production. Biotechnol Bioeng 2004, 86:747-755.
13. Salinas C.N., Anseth K.S. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials 2008, 29:2370-2377.
14. Appelman T.P., Mizrahi J., Elisseeff J.H., Seliktar D. The influence of biological motifs and dynamic mechanical stimulation in hydrogel scaffold systems on the phenotype of chondrocytes. Biomaterials 2011, 32:1508-1516.
15. Bryant S.J., Anseth K.S. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage. JBiomed Mater Res A 2003, 64:70-79.
16. Butterfield K.C., Conovaloff A.W., Panitch A. Development of affinity-based delivery of NGF from a chondroitin sulfate biomaterial. Biomater 2011, 1:174-181.
17. Ifkovits J.L., Burdick J.A. Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng B Rev 2007, 13:2369-2385.
18. Perez C.M.R., Panitch A., Chmielewski J. Acollagen peptide-based physical hydrogel for cell encapsulation. Macromol Biosci 2011, 11:1426-1431.
19. Roberts J.J., Elder R.M., Neumann A.J., Jayaraman A., Bryant S.J. Interaction of hyaluronan binding peptides with glycosaminoglycans in poly(ethylene glycol) hydrogels. Biomacromolecules 2014, 15:1132-1141.
20. Bahney C.S., Hsu C.-W., Yoo J.U., West J.L., Johnstone B. Abioresponsive hydrogel tuned to chondrogenesis of human mesenchymal stem cells. FASEB 2011, 25:1486-1496.
21. Nicodemus G.D., Bryant S.J. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng B Rev 2008, 14:149-165.
22. Martens P.J., Bryant S.J., Anseth K.S. Tailoring the degradation of hydrogels formed from multivinyl poly(ethylene glycol) and poly(vinyl alcohol) macromers for cartilage tissue engineering. Biomacromolecules 2003, 4:283-292.
23. Rice M.A., Anseth K.S. Encapsulating chondrocytes in copolymer gels: bimodal degradation kinetics influence cell phenotype and extracellular matrix development. JBiomed Mater Res A 2004, 70:560-568.
24. Sahoo S., Chung C., Khetan S., Burdick J.A. Hydrolytically degradable hyaluronic acid hydrogels with controlled temporal structures. Biomacromolecules 2008, 9:1088-1092.
25. Levesque S.G., Shoichet M.S. Synthesis of enzyme-degradable, peptide-cross-linked dextran hydrogels. Bioconjug Chem 2007, 18:874-885.
26. Rizzi S.C., Hubbell J.A. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part I: development and physicochemical characteristics. Biomacromol 2005, 6:1226-1238.
27. Ramshaw J.A.M., Peng Y.Y., Glattauer V., Werkmeister J.A. Collagens as biomaterials. JMater Sci Mater Med 2009, 20:S3-S8.
28. Werkmeister J.A., Ramshaw J.A.M. Recombinant protein scaffolds for tissue engineering. Biomed Mater 2012, 7:1-30.
29. Cosgriff-Hernandez E., Hahn M.S., Russell B., Wilems T., Munoz-Pinto D., Browning M.B., et al. Bioactive hydrogels based on designer collagens. Acta Biomater 2010, 6:3969-3977.
30. Peng Y.Y., Yoshizumi A., Danon S.J., Glattauer V., Prokopenko O., Mirochnitchenko O., et al. Streptococcus pyogenes derived collagen-like protein as a non-cytotoxic and non-immunogenic cross-linkable biomaterial. Biomaterials 2010, 31:2755-2761.
31. Peng Y.Y., Howell L., Stoichevska V., Werkmeister J.A., Dumsday G.J., Ramshaw J.A.M. Towards scalable production of a collagen-like protein from Streptococcus pyogenes for biomedical applications. Microb Cell Fact 2012, 11:146-153.
32. Peng Y.Y., Stoichevska V., Schacht K., Werkmeister J.A., Ramshaw J.A.M. Engineering multifunctional biological motifs into an inert structural collagen-like template from Streptococcal pyogenes. JBiomed Mater Res 2014, 102A:2189-2196.
33. Qing G., Ma L.C., Khorchid A., Swapna G.V., Mal T.K., Takayama M.M. Coldshock induced high-yield protein production in Escherichia coli. Nat Biotechnol 2004, 22:877-882.
34. Yoshizumi A., Yu Z., Silva T., Thiagarajan G., Ramshaw J.A.M., Inouye M. Self-association of Streptococcus pyogenes collagen-like constructs into higher order structures. Protein Sci 2009, 18:1241-1251.
35. Xu Y., Keene D.R., Bujnicki J.M., Höök M., Lukomski S. Streptococcal Scl1 and Scl2 proteins form collagen-like triple helices. JBiol Chem 2002, 277:27312-27318.
36. Mohs A., Silva T., Yoshida T., Amin R., Lukomski S., Inouye M., et al. Mechanism of stabilization of a bacterial collagen triple helix in the absence of hydroxyproline. JBiol Chem 2007, 282:29757-29765.
37. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nat 1970, 227:680-685.
38. Khire V., Lee T., Bowman C. Surface modification using thiol-acrylate conjugate addition reactions. Macromolecules 2007, 40:5669-5677.
39. St-Pierre J.-P., Gan L., Wang J., Pilliar R.M., Grynpas M.D., Kandel R.A. The incorporation of a zone of calcified cartilage improves the interfacial shear strength between invitro-formed cartilage and the underlying substrate. Acta Biomater 2012, 8:1603-1615.
40. Pfaffl M.W. Anew mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:2002-2007.
41. Guo Y., Yuan T., Ziao Z., Tang P., Xiao Y., Fan Y., et al. Hydrogels of collagen/chondroitin sulfate/hyaluronan interpenetrating polymer network for cartilage tissue engineering. JMater Sci 2012, 23:2267-2279.
42. Liu S.Q., Tian Q., Hedrick J.L., Hui J.H.P., Ee P.L.R., Yang Y.Y. Biomimetic hydrogels for chondrogenic differentiation of human mesenchymal stem cells to neocartilage. Biomaterials 2010, 31:631-640.
43. Cremer K.A., Rosloniec M.A. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. JMol Med 1998, 76:275-288.
44. Imai K., Yokohama Y., Nakanishi I., Ohuchi E., Fujii Y., Nakai N., et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. JBiol Chem 1995, 270:6691-6697.
45. Zhen E.Y., Brittain I.J., Laska D.A., Mitchell P.G., Sumer E.U., Karsdal M.A., et al. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheumatism 2008, 58:2420-2431.
46. Snoek-van Beurden P.A.M., Von den Hoff J.W. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. BioTechniques 2005, 38:73-83.
47. Ra H.-J., Harju-Baker S., Zhang F., Linhardt R.J., Wilson C.L., Parks W.C. Control of promatrilysin (MMP7) activation and substrate-specific activity by sulfated glycosaminoglycans. JBiol Chem 2009, 284:27924-27932.
48. Wilkinson JM. Fragmentation of polypeptides by enzymic methods. Practical protein chemistry: A handbook. Darbre A. John Wiley and Sons, New York, USA.
49. Flannery AV, Beynon RJ, Bond JS. Proteolysis of proteins for sequencing analysis and peptide mapping. Proteolytic enzymes: a practical approach. Beynon RJ, Bond JS. IRL Press, Oxford, UK.
50. Lefebvre V., Garofalo S., de Crombrugghe B. Type x collagen gene expression in mouse chondrocytes immortalized by a temperature-sensitive simian virus 40 large tumor antigen. JCell Biol 1995, 128:239-245.
51. Wang Q.G., Hughes N., Cartmell S.H., Kuiper N.J. The composition of hydrogels for cartilage tissue engineering can influence glycosaminoglycan profiles. Eur Cells Mater 2010, 19:86-95.
52. Yamamoto M., Adachi I.H., Maruyama Y., Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 2006, 231:20-27.
53. Purcell B.P., Lobb D., Charati M.B., Dorsey S.M., Wade R.J., Zellars K.N., et al. Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition. Nat Mater 2014, 13:653-661.
54. Feng Q., Zhu M., Wei K., Bian L. Cell-mediated degradation regulates human mesenchymal stem cell chondrogenesis and hypertrophy in MMP-sensitive hyaluronic acid hydrogels. Plos One 2014, 9.